180 related articles for article (PubMed ID: 35758193)
21. Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis.
Des Guetz G; Schischmanoff O; Nicolas P; Perret GY; Morere JF; Uzzan B
Eur J Cancer; 2009 Jul; 45(10):1890-6. PubMed ID: 19427194
[TBL] [Abstract][Full Text] [Related]
22. The Association Between Mutations in BRAF and Colorectal Cancer-Specific Survival Depends on Microsatellite Status and Tumor Stage.
Bläker H; Alwers E; Arnold A; Herpel E; Tagscherer KE; Roth W; Jansen L; Walter V; Kloor M; Chang-Claude J; Brenner H; Hoffmeister M
Clin Gastroenterol Hepatol; 2019 Feb; 17(3):455-462.e6. PubMed ID: 29660527
[TBL] [Abstract][Full Text] [Related]
23. The Clinical Significance of Microsatellite Instability in Patients with Right-sided Colorectal Cancer.
Han SA; Kim JH; Choi JH; Lee DH; Jung K; Kim SE; Moon W; Park MI; Park SJ
Korean J Gastroenterol; 2019 Mar; 73(3):159-166. PubMed ID: 31013559
[TBL] [Abstract][Full Text] [Related]
24. Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers.
Kim CG; Ahn JB; Jung M; Beom SH; Kim C; Kim JH; Heo SJ; Park HS; Kim JH; Kim NK; Min BS; Kim H; Koom WS; Shin SJ
Br J Cancer; 2016 Jun; 115(1):25-33. PubMed ID: 27228287
[TBL] [Abstract][Full Text] [Related]
25. Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
Tonello M; Baratti D; Sammartino P; Di Giorgio A; Robella M; Sassaroli C; Framarini M; Valle M; Macrì A; Graziosi L; Coccolini F; Lippolis PV; Gelmini R; Deraco M; Biacchi D; Santullo F; Vaira M; Di Lauro K; D'Acapito F; Carboni F; Giuffrè G; Donini A; Fugazzola P; Faviana P; Sorrentino L; Scapinello A; Del Bianco P; Sommariva A
Ann Surg Oncol; 2022 Jun; 29(6):3405-3417. PubMed ID: 34783946
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological predictors of benefit from adjuvant chemotherapy for stage C colorectal cancer: Microsatellite unstable cases benefit.
Thomas ML; Hewett PJ; Ruszkiewicz AR; Moore JW
Asia Pac J Clin Oncol; 2015 Dec; 11(4):343-51. PubMed ID: 26471980
[TBL] [Abstract][Full Text] [Related]
27. Carcinoma microsatellite instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for stage II rectal cancer.
Yang L; Sun Y; Huang XE; Yu DS; Zhou JN; Zhou X; Li DZ; Guan X
Asian Pac J Cancer Prev; 2015; 16(4):1545-51. PubMed ID: 25743829
[TBL] [Abstract][Full Text] [Related]
28. Microsatellite instability did not predict individual survival of unselected patients with colorectal cancer.
Lamberti C; Lundin S; Bogdanow M; Pagenstecher C; Friedrichs N; Büttner R; Sauerbruch T
Int J Colorectal Dis; 2007 Feb; 22(2):145-52. PubMed ID: 16724208
[TBL] [Abstract][Full Text] [Related]
29. Microsatellite Instability in Patients With Stage III Colon Cancer Receiving Fluoropyrimidine With or Without Oxaliplatin: An ACCENT Pooled Analysis of 12 Adjuvant Trials.
Cohen R; Taieb J; Fiskum J; Yothers G; Goldberg R; Yoshino T; Alberts S; Allegra C; de Gramont A; Seitz JF; O'Connell M; Haller D; Wolmark N; Erlichman C; Zaniboni A; Lonardi S; Kerr R; Grothey A; Sinicrope FA; André T; Shi Q
J Clin Oncol; 2021 Feb; 39(6):642-651. PubMed ID: 33356421
[TBL] [Abstract][Full Text] [Related]
30. Tumor LINE-1 methylation level and microsatellite instability in relation to colorectal cancer prognosis.
Inamura K; Yamauchi M; Nishihara R; Lochhead P; Qian ZR; Kuchiba A; Kim SA; Mima K; Sukawa Y; Jung S; Zhang X; Wu K; Cho E; Chan AT; Meyerhardt JA; Harris CC; Fuchs CS; Ogino S
J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25190725
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer.
Taieb J; Le Malicot K; Shi Q; Penault-Llorca F; Bouché O; Tabernero J; Mini E; Goldberg RM; Folprecht G; Luc Van Laethem J; Sargent DJ; Alberts SR; Emile JF; Laurent Puig P; Sinicrope FA
J Natl Cancer Inst; 2017 May; 109(5):. PubMed ID: 28040692
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of the combination of microsatellite instability and
Yang Y; Wang D; Jin L; Wu G; Bai Z; Wang J; Yao H; Zhang Z
Cancer Manag Res; 2018; 10():3911-3929. PubMed ID: 30310312
[TBL] [Abstract][Full Text] [Related]
33. Elevated Microsatellite Alterations at Selected Tetranucleotides (EMAST) in Colorectal Cancer is Associated with an Elderly, Frail Phenotype and Improved Recurrence-Free Survival.
Watson MM; Kanani A; Lea D; Khajavi RB; Søreide JA; Kørner H; Hagland HR; Søreide K
Ann Surg Oncol; 2020 Apr; 27(4):1058-1067. PubMed ID: 31686344
[TBL] [Abstract][Full Text] [Related]
34. Microsatellite Instability and Effectiveness of Adjuvant Treatment in pT1N1 Gastric Cancer: A Multicohort Study.
Oh N; Kim H; Kim KM; Cheong JH; Lee J; Noh SH; Sohn TS; Choi YY; An JY
Ann Surg Oncol; 2021 Dec; 28(13):8908-8915. PubMed ID: 34401986
[TBL] [Abstract][Full Text] [Related]
35. Lymphocytic infiltration in stage II microsatellite stable colorectal tumors: A retrospective prognosis biomarker analysis.
Sanz-Pamplona R; Melas M; Maoz A; Schmit SL; Rennert H; Lejbkowicz F; Greenson JK; Sanjuan X; Lopez-Zambrano M; Alonso MH; Qu C; McDonnell KJ; Idos GE; Vignali M; Emerson R; Fields P; Guinó E; Santos C; Salazar R; Robins HS; Rennert G; Gruber SB; Moreno V
PLoS Med; 2020 Sep; 17(9):e1003292. PubMed ID: 32970670
[TBL] [Abstract][Full Text] [Related]
36. Systematic review of microsatellite instability and colorectal cancer prognosis.
Popat S; Hubner R; Houlston RS
J Clin Oncol; 2005 Jan; 23(3):609-18. PubMed ID: 15659508
[TBL] [Abstract][Full Text] [Related]
37. Adjuvant Chemotherapy in Microsatellite Instability-High Gastric Cancer.
Kim JW; Cho SY; Chae J; Kim JW; Kim TY; Lee KW; Oh DY; Bang YJ; Im SA
Cancer Res Treat; 2020 Oct; 52(4):1178-1187. PubMed ID: 32599979
[TBL] [Abstract][Full Text] [Related]
38. Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) and Microsatellite Instability in Patients with Colorectal Cancer and Its Clinical Features.
Lee HS; Park KU; Kim DW; Lhn MH; Kim WH; Seo AN; Chang HE; Nam SK; Lee SY; Oh HK; Kang SB
Curr Mol Med; 2016; 16(9):829-839. PubMed ID: 27889996
[TBL] [Abstract][Full Text] [Related]
39. The prognostic significance of KRAS and BRAF mutation status in Korean colorectal cancer patients.
Won DD; Lee JI; Lee IK; Oh ST; Jung ES; Lee SH
BMC Cancer; 2017 Jun; 17(1):403. PubMed ID: 28583095
[TBL] [Abstract][Full Text] [Related]
40. Microsatellite instability: a predictive marker in metastatic colorectal cancer?
Des Guetz G; Uzzan B; Nicolas P; Schischmanoff O; Morere JF
Target Oncol; 2009 Jan; 4(1):57-62. PubMed ID: 19343302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
